Related Experiment Video
Updated: Dec 25, 2025

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
Published on: August 9, 2019
Rapalog-Mediated Repression of Tribbles Pseudokinase 3 Regulates Pre-mRNA Splicing
Bojana Stefanovska1,2,3, Cecile Edith Vicier1,2,3, Thibault Dayris2,4
1Inserm, UMR981, Villejuif, France.
Abstract:
Rapalogs have become standard-of-care in patients with metastatic breast, kidney, and neuroendocrine cancers. Nevertheless, tumor escape occurs after several months in most patients, highlighting the need to understand mechanisms of resistance. Using a panel of cancer cell lines, we show that rapalogs downregulate the putative protein kinase TRIB3 (tribbles pseudokinase 3). Blood samples of a small cohort of patients with cancer treated with rapalogs confirmed downregulation of TRIB3. Downregulation of TRIB3 was mediated by LRRFIP1 independently of mTOR and disrupted its interaction with the spliceosome, where it participated in rapalog-induced deregulation of RNA splicing. Conversely, overexpression of TRIB3 in a panel of cancer cell lines abolished the cytotoxic effects of rapalogs. These findings identify TRIB3 as a key component of the spliceosome, whose repression contributes significantly to the mechanism of resistance to rapalog therapy. SIGNIFICANCE: Independent of mTOR signaling, rapalogs induce cytoxicity by dysregulating spliceosome function via repression of TRIB3, the loss of which may, in the long term, contribute to therapeutic resistance.
Insights
Rapalogs fight cancer by disrupting RNA splicing through TRIB3 (tribbles pseudokinase 3). Loss of TRIB3 causes resistance to these therapies, independent of mTOR signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Rapalogs are standard-of-care for metastatic breast, kidney, and neuroendocrine cancers.
- Tumor resistance to rapalogs develops in most patients, necessitating understanding of resistance mechanisms.
Purpose of the Study:
- To investigate the role of TRIB3 (tribbles pseudokinase 3) in rapalog resistance.
- To elucidate the mechanism by which rapalogs induce cytotoxicity and how resistance develops.
Main Methods:
- Utilized a panel of cancer cell lines and patient blood samples.
- Investigated the interaction between rapalogs, TRIB3, LRRFIP1, and the spliceosome.
- Assessed the effect of TRIB3 overexpression on rapalog cytotoxicity.
Main Results:
- Rapalogs downregulate TRIB3 expression in cancer cell lines and in patients treated with rapalogs.
- TRIB3 downregulation, mediated by LRRFIP1, disrupts spliceosome interaction and RNA splicing.
- Overexpression of TRIB3 abrogated the cytotoxic effects of rapalogs.
Conclusions:
- TRIB3 is a key spliceosome component, and its repression contributes to rapalog resistance.
- Rapalogs induce cytotoxicity by dysregulating spliceosome function via TRIB3 repression, independent of mTOR signaling.
Related Concept Videos
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Transcriptional Regulation: Riboswitches
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Regulation of Expression at Multiple Steps
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Translational Regulation

